Hisun Pharmaceutical (Hangzhou)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Capreomycin | Capreomycin | 2018-10-18 | ||
| Cladribine | Cladribine | 2019-11-25 | 2024-2038 | |
| Dactinomycin | Dactinomycin | 2019-07-16 | ||
| Daptomycin | Daptomycin | 2021-04-21 | 2028-2041 | |
| Daunorubicin | Daunorubicin | 2019-04-25 | 2025-2032 | |
| Donepezil | Donepezil | 2017-03-24 | 2025-2038 | |
| Doxorubicin | Doxorubicin | 2019-05-13 | ||
| Epirubicin | Epirubicin | 2010-03-25 | ||
| Irbesartan | Irbesartan | 2016-06-14 | ||
| Irbesartan hydrochlorothiazide | Hydrochlorothiazide, Irbesartan | 2016-10-14 | ||
| Irinotecan | Irinotecan | 2009-01-28 | 2025-2036 | |
| Levetiracetam | Levetiracetam | 2017-09-28 | 2026-2034 | |
| Losartan potassium | Losartan potassium | 2019-04-04 | — |
1
2
>
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use